Zacks.com on MSN
Novavax Grants License for Use of Matrix-M Adjuvant to Pfizer
NVAX inks a non-exclusive Matrix-M license, securing $30M upfront, up to $500M in milestones and mid-single-digit royalties ...
Investing.com -- Axogen Inc (NASDAQ:AXGN) stock fell 5.3% in after-hours trading Wednesday following the company’s announcement of a planned $85 million public offering of common stock.
Stop losing technical sales to customer confusion. EcommerceFastlane shares a framework to simplify complex products and ...
ITAT Mumbai ruled that stamp duty rules under Section 50C do not apply to the transfer of a life interest in family trust property. The tribunal deleted an Rs 80 lakh capital gains tax addition, ...
Looking for help with today's New York Times Pips? We'll walk you through today's puzzle and help you match dominoes to tiles.
Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it intends to offer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback